Dyadic International expands license agreement With Abengoa
Green Car Congress
MAY 2, 2012
a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, biochemical, biopharmaceutical and industrial enzyme industries, $5.5 Abengoa will have the right to work with third party sublicensees to further develop C1 enzymes. Earlier post.).
210 
Let's personalize your content